Explore

Trendline Trendline
Verastem Oncology Reports Financial Results and Initiates New Cancer Trials

Verastem Oncology Reports Financial Results and Initiates New Cancer Trials

Verastem Oncology Reports Financial Results and Initiates New Cancer Trials
Trendline Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Trendline Trendline
Delcath Systems Reports Increased Revenue and Strategic Developments in Q1 2026

Delcath Systems Reports Increased Revenue and Strategic Developments in Q1 2026

Delcath Systems Reports Increased Revenue and Strategic Developments in Q1 2026
Trendline Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments

Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments

Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Trendline Trendline
Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies

Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies

Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies
Trendline Trendline
Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs

Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs

Vir Biotechnology Reports Strong Financial Position and Advances in Cancer and Hepatitis Delta Programs
Trendline Trendline
Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials
Trendline Trendline
EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress

EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress

EyePoint Pharmaceuticals Reports Q1 2026 Financial Results Amid Clinical Progress
Trendline Trendline
Janux Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Janux Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Janux Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Trendline Trendline
Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results

Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results

Personalis Secures Medicare Coverage for Lung Cancer, Reports Q1 Financial Results
Trendline Trendline
EyePoint Reports Q1 2026 Financial Results and Advances in Retinal Disease Therapies

EyePoint Reports Q1 2026 Financial Results and Advances in Retinal Disease Therapies

EyePoint Reports Q1 2026 Financial Results and Advances in Retinal Disease Therapies
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026